Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
life sciences
national blog main
3
×
boston blog main
indiana blog main
indiana top stories
national top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
aimmune therapeutics
allergy
alprazolam
amgen
anaphylaxis
andrew oxtoby
billy dunn
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
daniel edelman
detroit blog main
detroit top stories
drug enforcement administration
drug prices
drug pricing
eli lilly
eosinophilic esophagitis
europe top stories
evrysdi
food allergy
gene therapy
genentech
What
drug
3
×
fda
friday
3
×
approval
approved
new
oral
therapy
won
acute
addresses
agency
aimmune
allergy
atrophy
awarded
causes
condition
daily
decades
developed
eli
evrysdi
giant
giving
green
home
immunotherapy
intended
lasmiditan
late
lights
lilly
lilly’s
liquid
medication
medicine
migraine
muscular
oks
Language
unset
Current search:
fda
×
drug
×
" national blog main "
×
friday
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades